ALFA Filings
Every announcement, straight from the exchange
Every Novelix Pharmaceuticals other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
5 announcements
Novelix Pharmaceuticals Ltd has filed its quarterly shareholding pattern as per SEBI Regulation 31(1)(b) for the period ended September 30, 2026.
Novelix Pharmaceuticals informs shareholders that the Annual Report for FY 2025-26 and the 32nd AGM notice are available on the Company's website.
Novelix Pharmaceuticals filed its Statement of Deviation and Variation for the quarter ended June 30, 2026, reporting no deviations in fund utilization.
Novelix Pharmaceuticals declared non-applicability of the Annual Secretarial Compliance Report for FY2026. The company remains exempt due to being below SEBI LODR regulatory thresholds.
Novelix Pharmaceuticals Limited has announced its official website address as https://novelixpharma.com in compliance with SEBI Listing Regulations. The website contains all information required under Regulation 46 of the SEBI LODR Regulations, 2015.